Organ-on-chip Networking in Europe Joining forces for the future

Similar documents
Christina Miller Director, UK Research Office

European-South African Cooperation in Scientific and Technical Research

Finn Børlum Kristensen, MD, PhD Director, EUnetHTA Secretariat Danish Health and Medicines Authority (EUnetHTA Coordinator) Copenhagen, Denmark

SafeNano Norway in from concept to reality?

The Dutch National Research Agenda

Realising the FNH-RI: Roadmap. Karin Zimmermann (Wageningen Economic Research [WUR], NL)

Athens, ΕΘΝΙΚΟ ΙΔΡΥΜΑ ΕΡΕΥΝΩΝ NATIONAL HELLENIC RESEARCH FOUNDATION

Public Private Partnerships & Idea selection

Achievements of FP7 examples that make us proud

Case Study: the HTA Alliance

FET Flagships in Horizon 2020

The TTO circle workshop on "Technology Transfer in Nanotechnology"

Framework Programme 7 and SMEs. Amaury NEVE European Commission DG Research - Unit T4: SMEs

EBA Master Class The Benefits of International Collaboration. Steve Morgan Co-Chair, EBA Benchmarking Group

The BLUEMED Initiative: RESEARCH AND INNOVATION INITIATIVE FOR BLUE JOBS AND GROWTH IN THE MEDITERRANEAN

European Connected Health Alliance Bringing needs and solutions together for the Future of Health. ECHAlliance Update

Current Status and Challenges of Bilateral/Multilateral Meetings

H2020 Excellent science arie Skłodowska-Curie Actions. Your research career in Europe. 17 November 2015

Pre-Commercial Procurement (PCP) Actions

FET in H2020. European Commission DG CONNECT Future and Emerging Technologies (FET) Unit Ales Fiala, Head of Unit

'INNOVATIVE SOLUTIONS FOR RESEARCH IN HEALTHCARE' Developing a novel approach to deliver better precision medicine in Europe The EMA standpoint

Horizon the new EU Framework Programme for Research and Innovation

ehealth Ireland Ecosystem members of the ECHAlliance International Ecosystem Network European Ecosystem Network Update

THE DIGITALISATION CHALLENGES IN LITHUANIAN ENGINEERING INDUSTRY. Darius Lasionis LINPRA Director November 30, 2018 Latvia

How Paediatric Research Networks can help drug development

Funding Opportunities in Metrology Related Research

escience/lhc-expts integrated t infrastructure

Title of Presentation

Research Brief. Clinicians and life sciences companies working together: What types of relationships do clinicians find most appealing?

Materials Characterization Cluster A new European initiative

INNOSERV. An FP7 project on innovative social services

CDP-EIF ITAtech Equity Platform

Important note To cite this publication, please use the final published version (if applicable). Please check the document version above.

FET Open in Horizon Roumen Borissov Scientific/Technical Project Officer Future and Emerging Technologies, DG CONNECT European Commission

3 rd meeting of the Board of Funders Brussels, 30 June State of Play. Gustav Kalbe. Head of Unit, DG Connect European Commission

Internationalisation of universities Do we need strategies?

Current state of the debate regarding the role of Social Sciences and Humanities in Research and Innovation in the EU 1

EUROPEAN INNOVATION PARTNERSHIP FOR ACTIVE AND HEALTHY AGEING

Utrecht Region. At the heart of the Netherlands Life Sciences and Health industry. Why locate your life sciences company in the Utrecht Region?

Building the ERA of Knowledge for Growth. Proposals for the 7 th Research Framework Programme

Table Of Content. Stichting Health Action International... 2 Summary... 3 Coordinator, Leader contact and partners... 6 Outputs...

OPEN BOARD MEETING! Barcelona, 2 July 2015! 17:00 18:00!!

ISO INTERNATIONAL STANDARD. Nomenclature Specification for a nomenclature system for medical devices for the purpose of regulatory data exchange

Korean scientific cooperation network with the European Research Area KORANET. Korean scientific cooperation network with the European Research Area

Future and Emerging Technologies. Ales Fiala, Head of Unit C2 European Commission - DG CONNECT Directorate C - Excellence in Science

Convergence and Differentiation within the Framework of European Scientific and Technical Cooperation on HTA

Stakeholders Acting Together On the ethical impact assessment of Research and Innovation

Robotics: from FP7 to Horizon Libor Král, Head of Unit Unit A2 - Robotics DG Communication Networks, Content and Technology European Commission

Horizon Societal Challenge 1: Health, demographic change and wellbeing. Jeremy Bray DG Research & Innovation European Commission

The Rolling Agenda. 3-year strategic programme and 2-year work programme, what about it? Opportunities and obstacles

FLEXNET. Network of Excellence for FOLAE research in the EU

2013 UNECE Workshop on Rail Security Rail security initiatives at UITP Denis Luyten, UITP

International Conference on Research Infrastructures 2014

ISGAN Annex 7 Smart Grids Transitions

Public Consultation: Science 2.0 : science in transition

International Cooperation in Horizon 2020

Consultation on Long Term sustainability of Research Infrastructures

Synergies and Complementarities with EU Research & Innovation Policy

Rethinking the role of Social Sciences and Humanities (SSH) in Horizon 2020: toward a reflective and generative perspective

UNIVERSITE LIBRE DE BRUXELLES

Mobilisation and Mutual Learning (MML) Action Plans on Societal Challenges

Laurent Romary, Inria DARIAH, director DARIAH - SHAPING EUROPEAN RESEARCH IN THE ARTS AND HUMANITIES

AMPEA: The Joint Programme on Advanced Materials and Processes for Energy Applications

Written Submission for the Pre-Budget Consultations in Advance of the 2019 Budget By: The Danish Life Sciences Forum

Organization of European activities: status

LÜBECK SUMMER ACADEMY HOW DOES AI TARGET CHALLENGES IN HEALTHCARE DIE SPEZIALISTEN FÜR KÜNSTLICHE INTELLIGENZ IM GESUNDHEITSWESEN

25 th Workshop of the EURORDIS Round Table of Companies (ERTC)

5.0% 0.0% -5.0% -10.0% -15.0% 10.0% 5.0% 0.0% -5.0% -10.0% -15.0% 10.0% 5.0% 0.0% -5.0% -10.0% 16.00% 13.00% 10.00% 7.00% 4.

Press Release Capacitive Identification Tokens (CAPID)

Bridging the gap between real Science & Technology opportunities and EU S&T policies

PPP InfoDay Brussels, July 2012

Research Development Request - Profile Template. European Commission

The BLUEMED INITIATIVE: objectives, achievements and future actions

Deliverable D6.3 DeMStack

Offshore Renewable Energy Conversion platforms - Coordination Action

Green Paper - From Challenges to Opportunities: Towards a Common Strategic Framework. for EU Research and Innovation Funding

Re-engineering Collaborative Mechanisms and Knowledge Networks to Accelerate Innovation for Alzheimer s

EU s Innovative Medical Technology and EMA s Measures

Nanomaterials: Applications, Implications and Safety Management in the SAICM Context Rob Visser

Tecan Group. Corporate Update CONFERENCE CALL JANUARY 15, 2019

Robotics in the healthcare domain / DIH status and future

Final Minutes of EMA/EUnetHTA meeting

Funding opportunities for BigSkyEarth projects. Darko Jevremović Brno, April

Women on Boards. Vanessa Williams Managing Director, Awen Consultants Limited Founder, Governance for Growth Director & Lawyer, Excello Law Limited

EC-Egypt Science and Technology Cooperation Agreement. Road Map

Shaping Europe s Digital Future

STRUCTURE OF THE H2020 PROPOSAL, TYPES OF ACTIONS, TLR. Summer School for Young Researchers, September 2017, Odessa

Optimaliseren van Impact door Alfa- en Gammawetenschappen

Franco German press release. following the interview between Ministers Le Maire and Altmaier, 18 December.

THE EUROPEAN COUNCIL OF ACADEMIES OF APPLIED SCIENCES, TECHNOLOGIES AND ENGINEERING

Utrecht Region. A key role in the Netherlands medical technology industry. Why locate your medical technology company in the Utrecht Region?

OBN BioTuesday: Sources of Public Non-Dilutable Funding & Export Support to UK R&D Companies

PERSONA. Privacy, ethical, regulatory and social nogate crossing point solutions acceptance. István BÖRÖCZ

DARIAH-ERIC. Towards a sustainable social and technical European eresearch Infrastructure for the Arts and Humanities

AI in H2020. Artificial Intelligence for Europe WP Upcoming Calls

Supporting Innovation through Regulation and Science

SECTEUR Ascertaining user needs

Response to EC Framework 7 proposals for ICT

Introduction to the Cypriot Node for Maritime Surveillance

ECTP & EurekaBuild. Jesús Rodríguez ECTP SG chairman EurekaBuild chairman DRAGADOS (ACS Group), Spain

Transcription:

Organ-on-chip Networking in Europe Joining forces for the future Janny van den Eijnden van Raaij Managing director hdmt EMA workshop Organ-on-Chip London 5 October 2017

Topics to be addressed hdmt Organ-on-Chip Consortium European Organ-on-Chip network Future EU funding opportunities EU ORCHID project

hdmt s dream Imagine: organ-on-chip models that mimic any part of the human body, to study human sickness and health, for personalized disease treatment or even prevention available and affordable for everyone.

Towards an Organ-on-Chip Institute Organ-on-chip on Dutch scientific agenda in 2011 Royal Netherlands Academy of Arts and Sciences Beyond Borders program (2011-2013) Regenerative Medicine Personalised Medicine Brain, recognition and behavior Dutch Technology Consortium in 2012 International Lorentz conference Leiden in 2012 Bottom-up development of new technologybased institute (2013-2014) hdmt Foundation in February 2015 hdmt Consortium in September 2015 Organ-on-chip/hDMT in Topsectors: Chemistry (Roadmap Chem. Nanotech.and Devices) LSH (Roadmap Regenerative Medicine) HTSM (Roadmap Nanotechnology)

Partners Organ-on-chip Consortium Since 2015

Organ-on-chip Consortium Since 2015 Expertise Stem cell technology ipsc Adult stem cells (organoids) Tissue slices Read-out technology Microfluidics Microelectronics Microfabrication Polymer chemistry Computational modeling Focus Human organ and disease models Brain-on-chip Cancer-on-chip Heart-on-chip Vessels-on-chip Gut-on-Chip Skin-on-Chip Other Organ-on-chip technology platforms Metabolism Food toxicology Drug development expertise Validation/valorization

Organization Organ-on-chip Consortium Since 2015 Not for profit precompetitive technology institute hdmt Foundation + 14 partners, hdmt Partner Agreement Public-private partnership, multiple locations Unique integration of multidisciplinary expertise, technologies and facilities Open access publication Clinical Advisory Board, Patient Advocacy group (to be established) Collaboration with world-wide scientific research organizations (Europe, USA (Wyss)) Towards a Center of Excellence on human organ and disease models-onchip

Lobby/Image building Network formation Platform function Role of hdmt Project Management (Coordination and Monitoring) hdmt Central Coordinator Support (Grants, funding) Collaboration Facilitation Communication Bundling and exchanging expertise and facilities

hdmt Organ-on-chip Consortium COMPANY NETWORK hdmt Foundation Target companies hdmt partners Specialized suppliers Manufacturing companies Application needs Develop model Build prototype Validate model Industrialize VALORIZATION

Funding and networking NWO (Dutch Government) Netherlands organ-on-chip Initiative (NOCI) 18.8 M, 10 yr (start 1 Oct 2017) European Union H2020 EU programs 2018-2020 FET-PROACTIVE FET-FLAGSHIP MARIE SKLODOWSKA-CURIE Action (ITN) NMBP call DT-NMBP-23-2020 (Next generation organ-on-chip (RIA))

European organ-on-chip network Organ-on-chip in Europe Austria (University of Technology Graz, Vienna) Belgium (IMEC) France (CEA-LETI) Germany (Fraunhofer, UMC Hamburg, Tissuse Berlin) Greece (Nat. Techn University of Athens) Italy (IMM-CNR) Luxembourg (University) Portugal (University of Coimbra) Spain (University of Zaragoza) Sweden (Uppsala University) Switzerland (EPFL) The Netherlands (hdmt) and more partners to come

ORCHID (ORgan-on-CHip In Development) H2020 Future and Emerging Technologies (FET) program CSA Coordination and support action Goal: Create a roadmap for organ-on-chip technology Build a network of academia, research institutes, industry, regulatory bodies, patient organizations etc. Raise awareness by dissemination and communication

ORCHID objectives 1. Evaluation of the technology (state-of-the-art and unmet needs) 2. Identification of ethical issues, establishing standards and identifying measures for regulatory implementation 3. Analysis of economic and societal impact, training and education 4. Developing a roadmap which will guide the required R&D efforts 5. Raising awareness and building the ecosystem for organ-on-chip technology through a digital reference platform

ORCHID Consortium

ORCHID TAKE-OFF 1 October 2017 1 October 2019

www.hdmt.technology